5 completed, 3 unknown, 1 recruiting, 1 withdrawn. 10 Phase 2, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 10 | Completed 5, Unknown 3, Recruiting 1, Withdrawn 1 |
| Phase 3 | 2 | Completed 1, Unknown 1 |
Follow Ibandronic Acid: new trials by email Literature Review of Ibandronic Acid trials Research Report on Ibandronic Acid
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Zanzalintinib for Metastatic Clear Cell Renal Cell Carcinoma With Bone Metastases Zanzalintinib, Investigator Choice of Bone Strengthening Agents (BSA), Non-Investigational Radiation Therapy (RT) - Clear Cell Renal Cell Cancer (ccRCC), Clear Cell Renal Carcinoma | Phase 2 | Recruiting | Kelly Fitzgerald, MD | 20 | 2026-06-10 | 2026-07-27 |
| Coral Calcium's Effect on Bone Density in Postmenopausal Women With and Without Ibandronate Coral Complex 3, Ibandronate, Vitamin D3 - Osteoporosis, Postmenopausal | Phase 2 | Completed | Columbia University | 60 | 2020-02-05 | 2024-05-09 |
| Efficacy of Oral Ibandronate in Osteoporosis Ibandronate, Oral Ibandronate and Vitamin D - Osteoporosis | Phase 2 | Unknown | Shinshu University | 100 | 2017-10-12 | 2021-09-21 |
| Study of Oral Bisphosphonate for Osteopenic Women Treated With Adjuvant Aromatase Inhibitors Ibandronic acid, Placebo - Breast Cancer | Phase 2 | Completed | Azienda Ospedaliero-Universitaria Careggi | 171 | 2011-01-01 | 2019-10-22 |
| PTH & Ibandronate Combination Study (PICS) PTH(1-84), Ibandronate, Placebo injection - Osteoporosis | Phase 2 / Phase 3 | Completed | University of California, San Francisco | 44 | 2008-05-01 | 2013-11-05 |
| A Study of Loading Doses of Intravenous Bondronat (Ibandronate) in Patients With Breast Cancer and Malignant Bone Disease. ibandronate [Bondronat] - Pain; Bone Neoplasms; Neoplasm Metastasis | Phase 2 | Completed | Hoffmann-La Roche | 13 | 2008-01-01 | 2014-01-22 |
| A Study of Loading Doses of Intravenous Bondronat (Ibandronate) in Patients With Breast Cancer and Metastatic Bone Disease. ibandronate [Bondronat] - Pain, Bone Neoplasm | Phase 2 | Withdrawn | Hoffmann-La Roche | 2007-06-01 | 2017-08-16 | |
| Bisphosphonate Action on the Appendicular Skeleton: Evidence for Differential Effects Ibandronate, Risedronate, Alendronate - Post-menopausal Osteoporosis | Phase 2 | Completed | Sheffield Teaching Hospitals NHS Foundation Trust | 410 | 2007-04-01 | 2018-03-06 |
| Ibandronate Versus Placebo in the Prevention of Bone Loss After Renal Transplantation. Placebo, Ibandronate - Renal Transplant | Phase 2 / Phase 3 | Unknown | Smerud Medical Research International AS | 130 | 2007-01-01 | 2010-03-24 |
| Safety and Efficacy Study of Intravenous Loading Dose of Ibandronate in Breast Cancer Patients Ibandronic acid - Breast Cancer | Phase 2 | Unknown | University of Turku | 60 | 2006-10-01 | 2006-12-04 |
Neoplasm Metastasis (3) · Osteoporosis (3) · Bone Neoplasms (2) · Breast Neoplasms (2) · Osteoporosis, Postmenopausal (2) · Pain (2) · Carcinoma, Renal Cell (1) · Clear-cell metastatic renal cell carcinoma (1)
Hoffmann-La Roche (2) · Azienda Ospedaliero-Universitaria Careggi (1) · Columbia University (1) · Kelly Fitzgerald, MD (1) · Sheffield Teaching Hospitals NHS Foundation Trust (1) · Shinshu University (1) · Smerud Medical Research International AS (1) · University of California, San Francisco (1) · University of Turku (1)
United States (2) · Armenia (1) · Finland (1) · Greece (1) · Italy (1) · Japan (1) · Norway (1) · Turkey (Türkiye) (1) · United Kingdom (1)
Angela Rogers, Dr (1) · Dennis M. Black, PhD (1) · Eugene McCloskey, Dr (1) · John P Bilezikian, MD, PhD (1) · Kelly Fitzgerald, MD (1) · Knut T Smerud, MSc (1) · Lorenzo Livi, Professor (1) · Margaret Paggiosi, Dr (1) · Meattini Icro, M.D. (1) · Outi Paija, MD, PhD (1) · Rosemary Hannon, Dr (1)
PMID 22791766, PMID 23589163, PMID 30648627, PMID 38979716, PMID 39588131